Create an Account
  1. Home
  2. Medical News
  3. SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?

SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?

Meeting report with video, highlights and slides of PACE-CME symposium held at ESC 2016 in Rome

Articles 1-2 of 2

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.